a,bSinijchaya Sahawatwong, MD; a,cPunyaphat Sirithanabadeekul, MD; dVasiyapha Patanajareet, MD; aPenpun Wattanakrai, MD; a,bWilai Thanasarnaksorn, MD aDivision of Dermatology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand; bSamitivej Esthetics Institute,
aLeon Kircik, MD; bJulie C. Sung, BA; cLinda Stein-Gold, MD; bGary Goldenberg, MD aMount Sinai Medical Center, New York, New York; Indiana University School of Medicine, Indianapolis, Indiana; Physicians Skin
Frank Armstrong, DO; Laura Jordan, MS, MA, MLS Dr. Armstrong is from Armstrong Dermatology and Skin Cancer Center, Seminole, Florida. Ms. Jordan is from Lake Erie College of Osteopathic Medicine,
Douglas Mest, MD; Gail Humble, MD, Blue Pacific Aesthetic Medical Group, Hermosa Beach, California Abstract Injectable poly-L-lactic acid is United States Food and Drug Administration–approved for the restoration and/or correction
